ENDO 09 Speaker Francis Collins Nominated to Head NIH
Francis Collins, MD PhD, President Obama’s nominee for Director of the National Institutes of Health (NIH), presented a widely attended lecture as part of ENDO 09’s “Endocrinology and Society” noon plenary series...
|
Society’s EDC Position Statement Urges Collaboration and Precaution in the Formulation of EDC Policy
At its June 8 meeting, Council approved a new position statement on endocrine-disrupting chemicals. Society position statements are thoroughly vetted documents outlining the Society’s views on current and salient issues in the public-policy arena...
|
AMA HOD Reaffirms Society's Position on Bioidentical Hormones
In a continuing effort to advance The Endocrine Society's advocacy goals, the Society's delegates attended the American Medical Association's (AMA) Annual House of Delegates (HOD) meeting in Chicago in June...
|
Final NIH Guidelines Allow Older Stem Cell Lines, Disallow hESC Derived from SCNT
Earlier this week, the National Institutes of Health released its final Guidelines on Human Stem Cell Research. NIH received more than 49,000 comments in response to its request for feedback on the draft guidelines...
|
Endocrinology Positioned for Payment Increase amid Controversial Proposals in 2010 Medicare Fee Schedule
On the eve of the July 4th holiday, the Centers for Medicare and Medicaid Services (CMS) released its 2010 proposal for Medicare physician payment policies, which include some significant changes...
|
High-profile Coverage of Scientific Statement Positions Society as Top Media Source on EDCs
At ENDO 09 the Society released its inaugural Scientific Statement, which identifies EDCs as a significant concern to public health. Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement was authored by a task force...
|
